Loading cancer entity…
Loading cancer entity…
Clinical trials
11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03442985 | An Efficacy and Safety Study of Palovarotene for the Treatment of MO(MO-Ped) | terminated | Phase 2 | 193 | Clementia Pharmaceuticals Inc.INDUSTRY | 12 | Aug 1, 2022 | clinicaltrials |
| NCT00473850 | Establishing the Genetic Profile of Multiple Hereditary Exostoses (HME) in Families of BC | terminated | — | 2,000 | University of British ColumbiaOTHER | 1 | Apr 15, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Aug 1, 2022source: clinicaltrials